ICP Versus Intracranial Compliance Guided Management in SAH

Subarachnoid Hemorrhage (SAH) Clinical Trial

Official title:
Intracranial Pressure (ICP) Versus Intracranial Compliance (ICC) Guided Management in Subarachnoid Hemorrhage; - a Prospective, Randomized Trial.

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether treatment guided also by ICP mean wave amplitude improves outcome compared to international standard care in patients with SAH.

Clinical Trial Description

In this study SAH-patients are randomized to treatment based on international standard care (ICP/CPP guided therapy) or intracranial compliance (ICP mean wave amplitude) guided therapy in addition to ICP/CPP guided therapy. Main outcome variables are survival and neurological outcome after 3 and 12 months. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor)

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00248690
Study type	Interventional
Source	Oslo University Hospital
Contact
Status	Completed
Phase	N/A
Start date	November 2005
Completion date	June 2009

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01593267` - Barrow Ruptured Aneurysm Trial	N/A
Terminated	`NCT01585311` - Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)
Completed	`NCT00954551` - Serum Procalcitonin	N/A
Completed	`NCT03761654` - Detection of Myocardial Dysfunction in Non-severe Subarachnoid Hemorrhage (WFNS 1-2) Using Speckle-tracking Echocardiography (STRAIN)
Completed	`NCT02172703` - Non-invasive Brain Pressure Monitoring After Trauma or Hemorrhage	N/A